{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:34:41Z","timestamp":1787906081807,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003693","name":"Korea Institute of Science and Technology","doi-asserted-by":"publisher","award":["KIST-INNOPOL 2022-002"],"award-info":[{"award-number":["KIST-INNOPOL 2022-002"]}],"id":[{"id":"10.13039\/501100003693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.diabres.2023.110626","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T12:50:54Z","timestamp":1678971054000},"page":"110626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Association between antidiabetic drugs and the incidence of atrial fibrillation in patients with type 2 diabetes: A nationwide cohort study in South Korea"],"prefix":"10.1016","volume":"198","author":[{"given":"Sunyoung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongseong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanyang","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonyoung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Keon","family":"Yon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Do","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jung","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Youl","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.diabres.2023.110626_b0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"Lippi","year":"2021","journal-title":"Int J Stroke"},{"issue":"5","key":"10.1016\/j.diabres.2023.110626_b0010","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ijcard.2012.12.093","article-title":"Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century","volume":"167","author":"Ball","year":"2013","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.diabres.2023.110626_b0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1747493018765491","article-title":"Impact of atrial fibrillation on inpatient cost for ischemic stroke in the USA","volume":"14","author":"Mukherjee","year":"2019","journal-title":"Int J Stroke"},{"issue":"6","key":"10.1016\/j.diabres.2023.110626_b0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.116.023163","article-title":"Modifiable Risk Factors and Atrial Fibrillation","volume":"136","author":"Lau","year":"2017","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.diabres.2023.110626_b0025","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s11606-010-1340-y","article-title":"Diabetes Mellitus, Glycemic Control, and Risk of Atrial Fibrillation","volume":"25","author":"Dublin","year":"2010","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.diabres.2023.110626_b0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/0975-3583.59978","article-title":"The link between diabetes and atrial fibrillation: cause or correlation?","volume":"1","author":"Sun","year":"2010","journal-title":"J Cardiovasc Dis Res"},{"issue":"16","key":"10.1016\/j.diabres.2023.110626_b0035","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1136\/heartjnl-2013-303798","article-title":"Risk factors for atrial fibrillation and their population burden in postmenopausal women: the Women's Health Initiative Observational Study","volume":"99","author":"Perez","year":"2013","journal-title":"Heart"},{"issue":"11","key":"10.1016\/j.diabres.2023.110626_b0040","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.diabres.2023.110626_b0045","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","article-title":"Atrial fibrillation and diabetes mellitus: JACC review topic of the week","volume":"74","author":"Wang","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.diabres.2023.110626_b0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/dom.13512","article-title":"Atrial fibrillation and type 2 diabetes: prevalence, etiology, pathophysiology and effect of anti-diabetic therapies","volume":"21","author":"Bell","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2023.110626_b0055","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ijcard.2015.03.052","article-title":"Diabetes mellitus and atrial fibrillation: pathophysiological mechanisms and potential upstream therapies","volume":"184","author":"Goudis","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.diabres.2023.110626_b0060","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3389\/fphys.2018.01575","article-title":"Direct cardiac actions of sodium glucose cotransporter 2 inhibitors target pathogenic mechanisms underlying heart failure in diabetic patients","volume":"9","author":"Uthman","year":"2018","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.diabres.2023.110626_b0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.15420\/cfr.2018.44.1","article-title":"Treatment of heart failure with sodium-glucose cotransporter 2 inhibitors and other anti-diabetic drugs","volume":"5","author":"Zelniker","year":"2019","journal-title":"Card Fail Rev"},{"issue":"1","key":"10.1016\/j.diabres.2023.110626_b0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4158\/CS-2019-0472","article-title":"Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm \u2013 2020 Executive Summary","volume":"26","author":"Garber","year":"2020","journal-title":"Endocr Pract"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2023.110626_b0075","first-page":"S125","article-title":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022","volume":"45","author":"Draznin","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110626_b0080","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3389\/fmed.2020.592901","article-title":"Metformin use is associated with a lower incidence of hospitalization for atrial fibrillation in patients with type 2 diabetes mellitus","volume":"7","author":"Tseng","year":"2021","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.diabres.2023.110626_b0085","doi-asserted-by":"crossref","first-page":"e009115","DOI":"10.1161\/CIRCEP.120.009115","article-title":"Metformin is associated with a lower risk of atrial fibrillation and ventricular arrhythmias compared with sulfonylureas: an observational study","volume":"14","author":"Ostropolets","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"10.1016\/j.diabres.2023.110626_b0090","first-page":"140","article-title":"Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: a nationwide cohort study","volume":"3","author":"Pallisgaard","year":"2017","journal-title":"Eur Heart J-Cardiovasc Pharmacother"},{"issue":"1","key":"10.1016\/j.diabres.2023.110626_b0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2020.04.041","article-title":"Incidence of cancer after asthma development: 2 independent population-based cohort studies","volume":"147","author":"Woo","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.diabres.2023.110626_b0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.7570\/jomes21056","article-title":"Obesity fact sheet in Korea, 2020: prevalence of obesity by obesity class from 2009 to 2018","volume":"30","author":"Nam","year":"2021","journal-title":"JOMES"},{"issue":"9","key":"10.1016\/j.diabres.2023.110626_b0105","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2337\/dc19-0760","article-title":"Association between glycemic status and the risk of Parkinson disease: a nationwide population-based study","volume":"43","author":"Rhee","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110626_b0110","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.54724\/lc.2022.e3","article-title":"Regression analysis for continuous independent variables in medical research: statistical standard and guideline of Life Cycle Committee","volume":"2","author":"Lee","year":"2022","journal-title":"Life Cycle"},{"issue":"1","key":"10.1016\/j.diabres.2023.110626_b0115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jdiacomp.2014.09.002","article-title":"Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes","volume":"29","author":"Rizzo","year":"2015","journal-title":"J Diabetes Complications"},{"issue":"23","key":"10.1016\/j.diabres.2023.110626_b0120","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1161\/01.CIR.0000018443.44005.D8","article-title":"Autonomic tone variations before the onset of paroxysmal atrial fibrillation","volume":"105","author":"Bettoni","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.diabres.2023.110626_b0125","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","article-title":"Diabetic Autonomic Neuropathy","volume":"26","author":"Vinik","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2023.110626_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-014-0123-x","article-title":"Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies","volume":"13","author":"Chang","year":"2014","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.diabres.2023.110626_b0135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12872-017-0531-4","article-title":"Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"15","key":"10.1016\/j.diabres.2023.110626_b0140","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.119.044183","article-title":"Effect of dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: insights from the DECLARE-TIMI 58 trial","volume":"141","author":"Zelniker","year":"2020","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.diabres.2023.110626_b0145","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00018-020-03648-y","article-title":"Effect of antidiabetic drugs on the risk of atrial fibrillation: mechanistic insights from clinical evidence and translational studies","volume":"78","author":"Lee","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.diabres.2023.110626_b0150","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijcard.2012.01.058","article-title":"Thiazolidinediones as novel upstream therapy for atrial fibrillation in diabetic patients: a review of current evidence","volume":"156","author":"Liu","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.diabres.2023.110626_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2013.09.016","article-title":"Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models","volume":"65","author":"Gu","year":"2013","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"10.1016\/j.diabres.2023.110626_b0160","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.hrthm.2010.10.029","article-title":"Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats","volume":"8","author":"Kume","year":"2011","journal-title":"Heart Rhythm"},{"issue":"Supplement_1","key":"10.1016\/j.diabres.2023.110626_b0165","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab724.0457","article-title":"Antidiabetic drugs use and new-onset atrial fibrillation in patients with diabetes mellitus","volume":"42","author":"Fauchier","year":"2021","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.diabres.2023.110626_b0170","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.hrthm.2021.03.007","article-title":"Comparison of the effect of glucose-lowering agents on the risk of atrial fibrillation: a network meta-analysis","volume":"18","author":"Shi","year":"2021","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.diabres.2023.110626_b0175","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4093\/dmj.2021.0156","article-title":"2021 Clinical practice guidelines for diabetes mellitus of the Korean Diabetes Association","volume":"45","author":"Hur","year":"2021","journal-title":"Diabetes Metab J"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723001018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723001018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:44:35Z","timestamp":1778730275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822723001018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":35,"alternative-id":["S0168822723001018"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110626","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between antidiabetic drugs and the incidence of atrial fibrillation in patients with type 2 diabetes: A nationwide cohort study in South Korea","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110626"}}